Marks MJ - Search Results

1

Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.

Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Grady SR, et al. Among authors: marks mj. J Pharmacol Exp Ther. 2002 May;301(2):651-60. doi: 10.1124/jpet.301.2.651. J Pharmacol Exp Ther. 2002. PMID: 11961070

2

Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.

Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. Mogg AJ, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):197-204. doi: 10.1124/jpet.302.1.197. J Pharmacol Exp Ther. 2002. PMID: 12065717

3

Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.

Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC. Marks MJ, et al. J Neurochem. 2002 Jun;81(5):1102-15. doi: 10.1046/j.1471-4159.2002.00910.x. J Neurochem. 2002. PMID: 12065623 Free article.

4

A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function.

Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. Dobelis P, et al. Among authors: marks mj. Mol Pharmacol. 2002 Aug;62(2):334-42. doi: 10.1124/mol.62.2.334. Mol Pharmacol. 2002. PMID: 12130686

5

Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.

Butt CM, Hutton SR, Marks MJ, Collins AC. Butt CM, et al. Among authors: marks mj. J Neurochem. 2002 Oct;83(1):48-56. doi: 10.1046/j.1471-4159.2002.01135.x. J Neurochem. 2002. PMID: 12358728 Free article.

6

Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.

Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC. Marks MJ, et al. Neuropharmacology. 2004 Jun;46(8):1141-57. doi: 10.1016/j.neuropharm.2004.02.009. Neuropharmacology. 2004. PMID: 15111021

7

Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR. Salminen O, et al. Among authors: marks mj. Mol Pharmacol. 2004 Jun;65(6):1526-35. doi: 10.1124/mol.65.6.1526. Mol Pharmacol. 2004. PMID: 15155845

8

The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.

Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. Salminen O, et al. Among authors: marks mj. Neuropharmacology. 2005 Apr;48(5):696-705. doi: 10.1016/j.neuropharm.2004.12.011. Neuropharmacology. 2005. PMID: 15814104

9

Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.

Marks MJ, Whiteaker P, Collins AC. Marks MJ, et al. Mol Pharmacol. 2006 Sep;70(3):947-59. doi: 10.1124/mol.106.025338. Epub 2006 May 25. Mol Pharmacol. 2006. PMID: 16728647

10

Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.

Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. Salminen O, et al. Among authors: marks mj. Mol Pharmacol. 2007 Jun;71(6):1563-71. doi: 10.1124/mol.106.031492. Epub 2007 Mar 6. Mol Pharmacol. 2007. PMID: 17341654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters